Cargando…
Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009
OBJECTIVE: Little is known regarding recent changes in glitazone use. RESEARCH DESIGN AND METHODS: Interrupted time series analyses of nationally representative office-visit data using IMS Health's National Disease and Therapeutic Index. RESULTS: From 2003 through 2005, glitazone use increased...
Autores principales: | Cohen, Andrew, Rabbani, Atonu, Shah, Nilay, Alexander, G. Caleb |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845035/ https://www.ncbi.nlm.nih.gov/pubmed/20103549 http://dx.doi.org/10.2337/dc09-1834 |
Ejemplares similares
-
111 Characterizing Physician Suicide in the U.S. (2003-2017)
por: Borota, Daniel, et al.
Publicado: (2022) -
Are the adverse effects of glitazones linked to induced testosterone deficiency?
por: Carruthers, M, et al.
Publicado: (2008) -
Pleiotropic Effects of Glitazones: A Double Edge Sword?
por: Salomone, Salvatore
Publicado: (2011) -
Glitazone use associated with reduced risk of Parkinson's disease
por: Brakedal, Brage, et al.
Publicado: (2017) -
Sexually transmitted infection laboratory testing and education trends in US outpatient physician offices, 2009–2016
por: Zeidan, Amina R, et al.
Publicado: (2021)